2022. Identification of biorelevant dissolution media to assess biopharmaceutical performance of erlotinib formulation with enhanced bioavailability using physiologybased pharmacokinetic modeling. Asian Journal of Pharmaceutics (AJP). 16, 2 (Jun. 2022). DOI:https://doi.org/10.22377/ajp.v16i2.4389.